BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34733658)

  • 1. Expression and clinical significance of NUF2 in kidney renal clear cell carcinoma.
    Shan L; Zhu XL; Zhang Y; Gu GJ; Cheng X
    Transl Androl Urol; 2021 Sep; 10(9):3628-3637. PubMed ID: 34733658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of matrix metalloproteinase 14 (MMP14) is associated with poor prognosis in renal clear cell carcinoma-a bioinformatics analysis.
    Zhao YW; Ma W; Jiang F; Xie Y; Tang L
    Transl Androl Urol; 2022 Nov; 11(11):1523-1534. PubMed ID: 36507474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of HADH is related to poor prognosis and immune infiltration in kidney renal clear cell carcinoma.
    Jiang H; Chen H; Wan P; Chen N
    Genomics; 2021 Nov; 113(6):3556-3564. PubMed ID: 34391866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and prognostic role of basic leucine zipper transcription factor in kidney renal clear cell carcinoma.
    Zhang H; Zhang H; Hu Y; Huang B; Chen J; Chen L
    Transl Androl Urol; 2022 Feb; 11(2):238-252. PubMed ID: 35280662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and clinical significance of DOK3 in renal clear cell carcinoma.
    Wang YF; Hu YQ; Hu YN; Bai YC; Wang H; Zhang Q
    J Int Med Res; 2023 May; 51(5):3000605231174974. PubMed ID: 37235715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GRAMD1A Is a Biomarker of Kidney Renal Clear Cell Carcinoma and Is Associated with Immune Infiltration in the Tumour Microenvironment.
    Liu Y; Fu S; Zhang Z; Wang S; Cheng X; Li Z; Ding Y; Sun T; Ma M
    Dis Markers; 2022; 2022():5939021. PubMed ID: 35860689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LAMTOR3 is a prognostic biomarker in kidney renal clear cell carcinoma.
    Gong Y; Lv Y; Xu F; Xiu Y; Lu Y; Liu Z; Deng L
    J Clin Lab Anal; 2022 Sep; 36(9):e24648. PubMed ID: 36082464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation of Hugl-2 is a prognostic biomarker in kidney renal clear cell carcinoma.
    Miao Y; Cao F; Li P; Liu P
    Clin Exp Pharmacol Physiol; 2021 Jan; 48(1):44-53. PubMed ID: 32754907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated CDC45 Expression Predicts Poorer Overall Survival Prognoses and Worse Immune Responses for Kidney Renal Clear Cell Carcinoma via Single-Cell and Bulk RNA-Sequencing.
    Zhang X; Zhou J; Wang Y; Wang X; Zhu B; Xing Q
    Biochem Genet; 2023 Aug; ():. PubMed ID: 37642814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Key Prognostic Value of Lysosomal Protein Transmembrane 5 in Kidney Renal Clear Cell Carcinoma.
    Li B; Shi XD
    Int J Gen Med; 2022; 15():2515-2527. PubMed ID: 35557976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic biomarker NEIL3 and its association with immune infiltration in renal clear cell carcinoma.
    Sun X; Liu P
    Front Oncol; 2023; 13():1073941. PubMed ID: 36816967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening.
    Han G; Zhao W; Song X; Kwok-Shing Ng P; Karam JA; Jonasch E; Mills GB; Zhao Z; Ding Z; Jia P
    BMC Genomics; 2017 Oct; 18(Suppl 6):678. PubMed ID: 28984208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Survival Risk and Immune-Related Characteristics of Kidney Renal Clear Cell Carcinoma.
    Wu X; Liang Y; Chen X; Long X; Xu W; Liu L; Wang B; Zou X
    J Immunol Res; 2022; 2022():6149369. PubMed ID: 35832648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Validation of Nine-RNA Binding Protein Signature Predicting Overall Survival for Kidney Renal Clear Cell Carcinoma.
    Zhong W; Huang C; Lin J; Zhu M; Zhong H; Chiang MH; Chiang HS; Hui MS; Lin Y; Huang J
    Front Genet; 2020; 11():568192. PubMed ID: 33133154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation expression and prognostic significance of Syntaxin4 in kidney renal clear cell carcinoma.
    He L; Jiang H; Lai Z; Zhong Z; Huang Z
    BMC Cancer; 2021 Sep; 21(1):992. PubMed ID: 34482824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival Prognosis, Tumor Immune Landscape, and Immune Responses of PPP1R18 in Kidney Renal Clear Cell Carcinoma and Its Potentially Double Mechanisms.
    Wang Y; Liu S; Chen Y; Zhu B; Xing Q
    World J Oncol; 2022 Feb; 13(1):27-37. PubMed ID: 35317332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma.
    Yu J; Mao W; Sun S; Hu Q; Wang C; Xu Z; Liu R; Chen S; Xu B; Chen M
    Front Oncol; 2021; 11():663263. PubMed ID: 34123820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulated Transcription Factor PITX1 Predicts Poor Prognosis in Kidney Renal Clear Cell Carcinoma-Based Bioinformatic Analysis and Experimental Verification.
    Zhang Y; Zhang Z; Zhang W; Hu H; Bao G
    Dis Markers; 2021; 2021():7694239. PubMed ID: 34868397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOA1 mRNA and protein in kidney renal clear cell carcinoma correlate with the disease outcome.
    Zeng W; Xiong G; Hua L; Hu Y; Guo X; Peng X
    Sci Rep; 2022 Jul; 12(1):12406. PubMed ID: 35858961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidant Gene Signature Impacts the Immune Infiltration and Predicts the Prognosis of Kidney Renal Clear Cell Carcinoma.
    Ren X; Ma L; Wang N; Zhou R; Wu J; Xie X; Zhang H; Liu D; Ma X; Dang C; Kang H; Zhou Z
    Front Genet; 2021; 12():721252. PubMed ID: 34490047
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.